Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MediSpectra Begins Cervical Imaging Pivotal Study On Strength Of Pilot Data

This article was originally published in The Gray Sheet

Executive Summary

MediSpectra is conducting a pivotal U.S. trial comparing its Luma cervical imaging detection system as an adjunct to colposcopy with colposcopy alone

You may also be interested in...



MediSpectra Cervical Imaging System Gains FDA Panel Review

FDA's Obstetrics & Gynecology Devices Panel will meet on May 17 to review data from a 13-site, 2,200-woman trial for MediSpectra's Luma spectroscopy-based cervical imaging system

MediSpectra Cervical Imaging System Gains FDA Panel Review

FDA's Obstetrics & Gynecology Devices Panel will meet on May 17 to review data from a 13-site, 2,200-woman trial for MediSpectra's Luma spectroscopy-based cervical imaging system

MediSpectra Luma Cervical Imaging System Granted Expedited Review

MediSpectra hopes itsLuma cervical imaging system PMA will be reviewed by FDA's Obstetrics & Gynecological Devices panel this fall and approved in early 2005

Related Content

UsernamePublicRestriction

Register

MT017415

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel